According to the literature, germline mutations of the PRUNE2 gene have been very scarcely investigated in other forms of cancers, despite somatic mutations playing a role in the pathogenesis of prostate cancer, leiomyosarcoma, and colorectal cancer among others [26,27,29,30,31]. The gene discussed is PRUNE2; the disease is prostate carcinoma.